Dosidal · Switzerland

Havrix 1440, Injektionssuspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:558 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 558
atc: J07BC02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1993-09-03
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J07BC02
authorisation_number: 558
form: SUPA
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 08.08.
name: Havrix 1440, Injektionssuspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
zTcc4-hj0bwhn7jFrthJ2v9vl6mkloAfreARDwu3nuGj2O81v3JgNzm7LWmn0cTTMSEutqO9d0tcODdLVmPaYw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:558 · Same medicine in other markets · Dosidal